Drugs Made In America Acquisition (DMII) Common Equity (2024 - 2025)
Drugs Made In America Acquisition (DMII) posted quarterly Common Equity of -$17.8 million for Q4 2025, down 15128.73% year-over-year from N/an in Q4 2024, and down 2.86% quarter-over-quarter from -$17.3 million in Q3 2025.
Drugs Made In America Acquisition (DMII) Common Equity (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMII) has reported Common Equity for 2 consecutive years, with -$17.8 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Common Equity fell 15128.73% year-over-year to -$17.8 million; the TTM figure through Dec 2025 stood at -$17.8 million (down 15128.73% YoY), while the FY2025 annual figure was -$17.8 million, down 15128.73% from the prior year.
- Common Equity fell to -$17.8 million in Q4 2025 per DMII's latest filing, from -$17.3 million in the prior quarter.
- Across five years, Common Equity topped out at -$116719.0 in Q4 2024 and bottomed at -$17.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | -10.94 Mn |
| 2 | Drugs Made In America Acquisition | 507.00 Mn | 507.00 Mn | - | -17.93 Mn |
| 3 | Cantor Equity Partners IV | 467.55 Mn | 467.55 Mn | - | -170,609.00 |
| 4 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | -16.30 Mn |
| 5 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | 316,106.00 |
| 6 | Gores Holdings X | 381.05 Mn | 380.85 Mn | - | -31.02 Mn |
| 7 | Agriculture & Natural Solutions Acquisition | 377.29 Mn | 377.04 Mn | - | -34.15 Mn |
| 8 | Blue Water Acquisition Corp. III | 342.12 Mn | 342.08 Mn | - | -9.48 Mn |
| 9 | Berto Acquisition | 313.96 Mn | 313.81 Mn | - | -13.81 Mn |
| 10 | New Providence Acquisition Corp. III | 313.81 Mn | 313.81 Mn | - | -13.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -17.77 Mn |
| Sep 30, 2025 | -17.28 Mn |
| Dec 31, 2024 | -116,719.00 |